Before the COVID-19 lockdowns and social distancing measures put face-to-face business routines and conference attendance on hold, Carlo Rivis was a regular on the investor meeting circuit, building up awareness of the mathematical modeling technologies that he says will one day be a viable alternative to traditional clinical trials.
Computational Life is one of the few companies developing this technology, which uses software to simultaneously simulate the dynamics of...